These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes. Perera D; Poulos RC; Shah A; Beck D; Pimanda JE; Wong JW Nature; 2016 Apr; 532(7598):259-63. PubMed ID: 27075100 [TBL] [Abstract][Full Text] [Related]
4. A small-cell lung cancer genome with complex signatures of tobacco exposure. Pleasance ED; Stephens PJ; O'Meara S; McBride DJ; Meynert A; Jones D; Lin ML; Beare D; Lau KW; Greenman C; Varela I; Nik-Zainal S; Davies HR; Ordoñez GR; Mudie LJ; Latimer C; Edkins S; Stebbings L; Chen L; Jia M; Leroy C; Marshall J; Menzies A; Butler A; Teague JW; Mangion J; Sun YA; McLaughlin SF; Peckham HE; Tsung EF; Costa GL; Lee CC; Minna JD; Gazdar A; Birney E; Rhodes MD; McKernan KJ; Stratton MR; Futreal PA; Campbell PJ Nature; 2010 Jan; 463(7278):184-90. PubMed ID: 20016488 [TBL] [Abstract][Full Text] [Related]
5. Signatures of mutation and selection in the cancer genome. Bignell GR; Greenman CD; Davies H; Butler AP; Edkins S; Andrews JM; Buck G; Chen L; Beare D; Latimer C; Widaa S; Hinton J; Fahey C; Fu B; Swamy S; Dalgliesh GL; Teh BT; Deloukas P; Yang F; Campbell PJ; Futreal PA; Stratton MR Nature; 2010 Feb; 463(7283):893-8. PubMed ID: 20164919 [TBL] [Abstract][Full Text] [Related]
6. Signatures of mutational processes in human cancer. Alexandrov LB; Nik-Zainal S; Wedge DC; Aparicio SA; Behjati S; Biankin AV; Bignell GR; Bolli N; Borg A; Børresen-Dale AL; Boyault S; Burkhardt B; Butler AP; Caldas C; Davies HR; Desmedt C; Eils R; Eyfjörd JE; Foekens JA; Greaves M; Hosoda F; Hutter B; Ilicic T; Imbeaud S; Imielinski M; Jäger N; Jones DT; Jones D; Knappskog S; Kool M; Lakhani SR; López-Otín C; Martin S; Munshi NC; Nakamura H; Northcott PA; Pajic M; Papaemmanuil E; Paradiso A; Pearson JV; Puente XS; Raine K; Ramakrishna M; Richardson AL; Richter J; Rosenstiel P; Schlesner M; Schumacher TN; Span PN; Teague JW; Totoki Y; Tutt AN; Valdés-Mas R; van Buuren MM; van 't Veer L; Vincent-Salomon A; Waddell N; Yates LR; ; ; ; ; Zucman-Rossi J; Futreal PA; McDermott U; Lichter P; Meyerson M; Grimmond SM; Siebert R; Campo E; Shibata T; Pfister SM; Campbell PJ; Stratton MR Nature; 2013 Aug; 500(7463):415-21. PubMed ID: 23945592 [TBL] [Abstract][Full Text] [Related]
7. Recurrent somatic mutations reveal new insights into consequences of mutagenic processes in cancer. Stobbe MD; Thun GA; Diéguez-Docampo A; Oliva M; Whalley JP; Raineri E; Gut IG PLoS Comput Biol; 2019 Nov; 15(11):e1007496. PubMed ID: 31765368 [TBL] [Abstract][Full Text] [Related]
8. Mutational signature SBS8 predominantly arises due to late replication errors in cancer. Singh VK; Rastogi A; Hu X; Wang Y; De S Commun Biol; 2020 Aug; 3(1):421. PubMed ID: 32747711 [TBL] [Abstract][Full Text] [Related]
9. The evolutionary history of 2,658 cancers. Gerstung M; Jolly C; Leshchiner I; Dentro SC; Gonzalez S; Rosebrock D; Mitchell TJ; Rubanova Y; Anur P; Yu K; Tarabichi M; Deshwar A; Wintersinger J; Kleinheinz K; Vázquez-García I; Haase K; Jerman L; Sengupta S; Macintyre G; Malikic S; Donmez N; Livitz DG; Cmero M; Demeulemeester J; Schumacher S; Fan Y; Yao X; Lee J; Schlesner M; Boutros PC; Bowtell DD; Zhu H; Getz G; Imielinski M; Beroukhim R; Sahinalp SC; Ji Y; Peifer M; Markowetz F; Mustonen V; Yuan K; Wang W; Morris QD; ; Spellman PT; Wedge DC; Van Loo P; Nature; 2020 Feb; 578(7793):122-128. PubMed ID: 32025013 [TBL] [Abstract][Full Text] [Related]
10. Whole genome sequencing of matched primary and metastatic acral melanomas. Turajlic S; Furney SJ; Lambros MB; Mitsopoulos C; Kozarewa I; Geyer FC; Mackay A; Hakas J; Zvelebil M; Lord CJ; Ashworth A; Thomas M; Stamp G; Larkin J; Reis-Filho JS; Marais R Genome Res; 2012 Feb; 22(2):196-207. PubMed ID: 22183965 [TBL] [Abstract][Full Text] [Related]
11. Patterns and processes of somatic mutations in nine major cancers. Jia P; Pao W; Zhao Z BMC Med Genomics; 2014 Feb; 7():11. PubMed ID: 24552141 [TBL] [Abstract][Full Text] [Related]
12. The mutational burden of acral melanoma revealed by whole-genome sequencing and comparative analysis. Furney SJ; Turajlic S; Stamp G; Thomas JM; Hayes A; Strauss D; Gavrielides M; Xing W; Gore M; Larkin J; Marais R Pigment Cell Melanoma Res; 2014 Sep; 27(5):835-8. PubMed ID: 24913711 [TBL] [Abstract][Full Text] [Related]
13. Somatic mutation load and spectra: A record of DNA damage and repair in healthy human cells. Saini N; Gordenin DA Environ Mol Mutagen; 2018 Oct; 59(8):672-686. PubMed ID: 30152078 [TBL] [Abstract][Full Text] [Related]
14. Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes. Bleeker FE; Lamba S; Rodolfo M; Scarpa A; Leenstra S; Vandertop WP; Bardelli A Hum Mutat; 2009 Feb; 30(2):E451-9. PubMed ID: 19058223 [TBL] [Abstract][Full Text] [Related]
15. Mutation Signatures Depend on Epigenomic Contexts. Coleman N; De S Trends Cancer; 2018 Oct; 4(10):659-661. PubMed ID: 30292349 [TBL] [Abstract][Full Text] [Related]
16. Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response. Kumar Y; Yang J; Hu T; Chen L; Xu Z; Xu L; Hu XX; Tang G; Wang JM; Li Y; Poon WS; Wan W; Zhang L; Mat WK; Pun FW; Lee P; Cheong TH; Ding X; Ng SK; Tsang SY; Chen JF; Zhang P; Li S; Wang HY; Xue H BMC Med Genomics; 2015 Jul; 8():42. PubMed ID: 26208496 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profiling. Cifola I; Pietrelli A; Consolandi C; Severgnini M; Mangano E; Russo V; De Bellis G; Battaglia C PLoS One; 2013; 8(5):e63597. PubMed ID: 23704925 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying mutational signatures in human cancers. Helleday T; Eshtad S; Nik-Zainal S Nat Rev Genet; 2014 Sep; 15(9):585-98. PubMed ID: 24981601 [TBL] [Abstract][Full Text] [Related]
20. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. McGranahan N; Favero F; de Bruin EC; Birkbak NJ; Szallasi Z; Swanton C Sci Transl Med; 2015 Apr; 7(283):283ra54. PubMed ID: 25877892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]